About Mount Sinai’s Kidney / Pancreas Transplant Program
Mount Sinai’s Kidney/Pancreas Transplant Program is one of the nation’s leading academic kidney transplant programs. Since our inception in 1967, we have performed more than 2,500 adult and pediatric kidney transplants.
One of the first kidney transplant programs in the Northeast, we have made significant strides in providing more options for patients previously denied access to transplantation due to medical factors. We are on pace to perform more than 200 kidney transplants in 2012, with patient outcomes that exceed national outcomes.
Comprehensive, Multidisciplinary Care
Located in New York City, the Kidney/Pancreas Transplant Program is part of Mount Sinai’s Recanati/Miller Transplant Institute (RMTI), a comprehensive adult and pediatric abdominal organ transplantation center. Our multidisciplinary team includes experts in nephrology, surgery, anesthesiology, critical care, transplant immunology, and urology. This interdisciplinary approach allows us to provide the best in patient care by taking advantage of the most innovative developments in surgical techniques and transplant medicine. Patients who come to our program have access to the services of Mount Sinai Medical Center, an internationally acclaimed medical institution.
Increasing the Number of Donors
Mount Sinai has one of the largest living donor programs in the United States. Half of the yearly transplants performed involve living donors. As part of our commitment to enhancing quality of life for patients before and after transplant, surgeons at our hospital performed the first laparoscopic donor surgery in New York State in 1996. This procedure dramatically reduces recovery time for individuals donating a kidney to a loved one. So far, more than 500 laparoscopic donor surgeries have been performed in our transplant institute.
Our newly endowed Zweig Family Center for Living Donation focuses on providing the best in medical, surgical, and psychological care to living organ donors. The Zweig Family Center for Living Donation is further developing Altruistic and Donor Exchange programs which will enable all potential recipients to have optimal opportunities to access live donor transplantation.
Mount Sinai is one of the first programs in the country to offer “donor exchanges.” This innovative program enables kidney transplant recipients who have willing but incompatible living donors to exchange kidneys with compatible donors. We participate in local and national paired exchange programs and donor chain initiatives.
Increasing Clinical Eligibility
Mount Sinai has made great progress in increasing the eligibility of patients previously denied transplantation due to clinical factors. For example, Mount Sinai has an active Paired Kidney Exchange program allowing patients with incompatible donors to receive compatible organs through a process commonly known as a “kidney swap”. We developed and implemented a successful desensitization program to reduce the effects of antibodies that may hinder the ability of many to receive a successful transplant. We can now treat many patients who, due to their high immunologic risk, were previously ineligible for transplantation.
In addition, HIV-positive patients may be eligible for kidney transplant despite the fact that they have the virus that causes AIDS. Due to therapeutic advances in HIV/AIDS care, those with the AIDS virus now can be considered as candidates for transplantation. Mount Sinai is one of the few programs in the country with the expertise to successfully transplant these patients. We can also perform kidney transplants in patients with hepatitis C.
Our Pediatric Renal Transplant Program is the largest such program in the Northeast, and the fifth largest program in the nation.
Mount Sinai is one of the few centers in the New York region that offers pancreas transplantation as a surgical option for people with type I diabetes. Mount Sinai offers world-class care through a wide variety of organ transplants. We have extensive experience in multi-organ transplants, including combined liver-kidney transplants and heart-kidney transplants.
Mount Sinai researchers are working hard to improve organ preservation, reduce rejection, minimize postsurgical complications and the side effects of immunosuppression, and prevent the recurrence of disease.
Two large NIH-funded multicenter trials in transplantation are ongoing. Barbara Murphy, MD, is leading a genomics in transplantation study focusing on mechanisms of late graft injury, and Peter S. Heeger, MD, is running the Clinical Trials in Organ Transplantation Consortium, which is evaluating biomarkers as predictors of heart or kidney transplant outcome. Both studies are enrolling new patients. Additional efforts focus on mechanisms of ischemic injury and the pathophysiology of rejection in kidney and liver transplant patients.
We Can Help
For more information or to schedule an appointment, please call 212-659-8086.
Tel: 212-731-RMTI (7684)
Adult Liver Diseases, Liver/Bile Duct Surgery, and Liver Transplantation
Pediatric Liver Diseases/Liver Transplantation Program
Kidney/Pancreas Transplantation Program
Intestinal Rehabilitation and Transplantation Program
The Zweig Family Center for Living Donation
RMTI team explains the transplantation evaluation process for organ donors and recipients. Watch Videos